'Era of Three-Way Competition for "Dream Cancer Therapy with Carbon Ion Beams" Approaching in Korea'
Gijang Carbon Ion Center Nears Completion of Equipment Installation
Seoul National University Hospital to Open in 2027, Asan Medical Center in 2031
Hospitals Differentiating Through Clinical Experience, Regional Demand, and Multi-Ion Strategies
A new era of competition among three particle therapy machines, which are arriving in Korea ahead of the United States, is expected to begin soon. Including proton therapy, all of the so-called "Big Five" hospitals will offer particle therapy, signaling a major shift in cancer treatment strategies at large hospitals centered around particle beam equipment. There are also expectations that Korea will secure a favorable position in building clinical evidence for particle therapy, which remains insufficient globally.
According to the hospital community on August 3, Seoul National University Hospital is nearing completion of the installation of treatment equipment at the Gijang Carbon Ion Therapy Center in Gijang-gun, Busan. Equipment testing and fine beam calibration are currently underway. The facility may begin trial operations as early as the second half of this year. As the Gijang Center accelerates its timeline, competition for carbon ion therapy among Severance Hospital, Seoul National University Hospital, and Asan Medical Center is becoming increasingly visible.
Each of these hospitals is pursuing a distinct strategy to differentiate itself. Severance Hospital's strength lies in its accumulated clinical experience. It was the first in Korea to begin carbon ion therapy in April 2023 and has treated patients for over three years. The hospital initially started with prostate cancer treatment, but since operating its rotating treatment machine in May 2024, it has expanded indications to pancreatic, liver, and lung cancers. Because performance in this field heavily depends on experienced personnel and specialized know-how, the early start has proven a significant advantage. Severance Hospital plans to further expand into head and neck cancers and to formalize combination therapy protocols integrating both anticancer drugs and surgery, leveraging experience gained through collaborations with institutions such as the QST National Institutes for Quantum Science and Technology in Japan.
Seoul National University Hospital is targeting demand outside the greater Seoul area. The Gijang Center will be the first carbon ion facility located outside the capital region, enabling it to serve patients in southern Korea who previously had to travel to Seoul. It will employ a superconducting rotating gantry, allowing beams to be delivered from various angles. The center aims to treat 11 types of cancer, including brain tumors, head and neck cancer, esophageal cancer, liver cancer, pancreatic cancer, and prostate cancer, and will also include patients who cannot receive additional radiation therapy and pediatric cancer patients. The facility is slated for opening in the second half of 2027.
Asan Medical Center is focusing on its competitive edge with three machines. Construction on its new center began on June 11, with the goal of commencing operations in 2031. The total floor space will be 39,502 square meters across 12 floors, making it the largest facility in Korea. The center will feature two rotating machines and one fixed machine. It will use the "multi-ion beam" approach, enabling the selection of various ions—including helium, neon, and oxygen in addition to carbon—according to the patient's condition. This technology further reduces damage to normal tissues and opens the possibility of treating pediatric tumors.
Carbon ion therapy works by accelerating carbon atoms to near the speed of light and colliding them with cancer cells. This method concentrates radiation on the tumor while minimizing damage to normal tissues and is two to three times more powerful than conventional radiation. However, the equipment costs hundreds of billions of won, and as of December last year, there were only about 17 facilities worldwide. Most are located in Japan and Europe, and not a single machine has been installed yet in the United States, a leading country in healthcare. Although Mayo Clinic in Jacksonville announced plans to introduce the technology this January, actual treatment is not expected to begin until 2028.
The need for more clinical research remains a challenge. As a source in the hospital sector noted, "Because the technology was only recently adopted, there haven't been many large-scale clinical trials. The key issue is determining which cancer types benefit most." In a pancreatic cancer clinical trial published last year in the International Journal of Radiation Oncology, no major side effects were reported and local control rates at two years were high, but the original survival rate goal was not met.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Meanwhile, Samsung Medical Center and Seoul St. Mary’s Hospital have chosen to focus on proton therapy. Samsung Medical Center began offering this treatment in December 2015 and has performed about 100,000 procedures for over 8,000 patients over the past 10 years. Seoul St. Mary’s Hospital plans to invest more than 250 billion won in its next-generation proton therapy center, which will break ground in the first half of 2027 and open by the end of 2029.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.